- Young people are using drugs as escapism more than ever before
- The High-Stakes Race to Engineer New Psychedelic Drugs
- Is the World Ready for Extremely Effective Weight-Loss Drugs?
- Biotech labs are using AI inspired by DALL-E to invent new drugs
- What You Need to Know About Ozempic, the Diabetes Drug Fueling Hollywood’s Harmful Weight-Loss Obsession
A new report suggests the kids aren't alright.
Two groups have announced powerful new generative models that can design new proteins on demand not seen in nature.
A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.
As the buzz builds around Ozempic, here’s what you need to know about what it is, how it works, and who should—and, perhaps more importantly, shouldn’t—be taking it.
A new class of medicines has the potential to permanently change the way we think about obesity.
As psychedelic therapies for mental health go mainstream, companies are recruiting chemists to create patentable versions of hallucinogens. Critics say it’s all a bad trip.
Ars chats with author Maia Szalavitz about her book, Undoing Drugs
LSD in the ’60s; ecstasy in the ’80s; ‘smart’ drugs today: how we get high reflects the desires and fears of our times
Russell Brand has not used drugs for 10 years. He has a job, a house, a cat, good friends. But temptation is never far away. He wants to help other addicts, but first he wants us to feel compassion for those affected
Our in-depth reporting on innovation reveals and explains what’s really happening now to help you know what’s coming next. http://technologyreview.com/newsletters
Learn from the world’s greatest thinkers. Join us on https://www.youtube.com/c/bigthink.
The voice of 8 billion citizens.
This is the official Twitter account of ETH Zurich in English. Stay tuned for the latest news on research, technology and education. Deutscher Account: @eth
Big fits start here. @GQStyle @GQSports @GQRecommends
How does Refind curate?
It’s a mix of human and algorithmic curation, following a number of steps:
- We monitor 10k+ sources and 1k+ thought leaders on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
- In addition, our users save links from around the web using our Save buttons and our extensions.
- Our algorithm processes 100k+ new links every day and uses external signals to find the most relevant ones, focusing on timeless pieces.
- Our community of active users gets 5 links every day, tailored to their interests. They provide feedback via implicit and explicit signals: open, read, listen, share, add to reading list, save to «Made me smarter», «More/less like this», etc.
- Our algorithm uses these internal signals to refine the selection.
- In addition, we have expert curators who manually curate niche topics.
The result: lists of the best and most useful articles on hundreds of topics.
How does Refind detect «timeless» pieces?
We focus on pieces with long shelf-lives—not news. We determine «timelessness» via a number of metrics, for example, the consumption pattern of links over time.
How many sources does Refind monitor?
We monitor 10k+ content sources on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
Which sources does Refind monitor on drugs?
We monitor hundreds of sources on drugs, including MIT Technology Review, Big Think, GallupNews, ETH Zurich, GQ Magazine, and many more.
Can I submit a link?
Indirectly, by using Refind and saving links from outside (e.g., via our extensions).
How can I report a problem?
When you’re logged-in, you can flag any link via the «More» (...) menu. You can also report problems via email to firstname.lastname@example.org
Who uses Refind?
100k+ smart people start their day with Refind. To learn something new. To get inspired. To move forward. Our apps have a 4.9/5 rating.
Is Refind free?
Yes, it’s free!
How can I sign up?
Head over to our homepage and sign up by email or with your Twitter or Google account.